You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DOXYLAMINE SUCCINATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Doxylamine Succinate, and when can generic versions of Doxylamine Succinate launch?

Doxylamine Succinate is a drug marketed by Copley Pharm, LNK, Perrigo, Quantum Pharmics, Actavis Labs Fl Inc, Bionpharma, Endo Operations, and Mylan Pharms Inc. and is included in nine NDAs.

The generic ingredient in DOXYLAMINE SUCCINATE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DOXYLAMINE SUCCINATE?
  • What are the global sales for DOXYLAMINE SUCCINATE?
  • What is Average Wholesale Price for DOXYLAMINE SUCCINATE?
Drug patent expirations by year for DOXYLAMINE SUCCINATE
Recent Clinical Trials for DOXYLAMINE SUCCINATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hegang Maternal and Child Health HospitalPhase 3
Shuangyashan Maternal and Child Health HospitalPhase 3
Luoyang Hospital of TCMPhase 3

See all DOXYLAMINE SUCCINATE clinical trials

Pharmacology for DOXYLAMINE SUCCINATE
Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Medical Subject Heading (MeSH) Categories for DOXYLAMINE SUCCINATE
Anatomical Therapeutic Chemical (ATC) Classes for DOXYLAMINE SUCCINATE

US Patents and Regulatory Information for DOXYLAMINE SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copley Pharm DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 088900-002 Feb 12, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 208518-001 Dec 6, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Quantum Pharmics DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 088603-001 Aug 7, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Pharms Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 207825-001 Jul 6, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lnk DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040564-001 Aug 27, 2004 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040167-001 Sep 18, 1996 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.